press release
#Domain #Therapeutics #progress #clinical #trials Domain Therapeutics to progress into clinical trials with its EP4R antagonist DT-9081 in solid tumors Clinical trial applications accepted...
Hi, what are you looking for?
#Domain #Therapeutics #progress #clinical #trials Domain Therapeutics to progress into clinical trials with its EP4R antagonist DT-9081 in solid tumors Clinical trial applications accepted...
#Domain #Therapeutics #present #data #EP4R Domain Therapeutics to present new data on its EP4R and CCR8 antagonists at 2022 SITC Annual Meeting Domain will...